MedTrace Logo

Medication Monitoring for Older Adults in Primary Care

NCT04663360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2021-10-07

No results posted yet for this study

Summary

Polypharmacy has the potential to harm older adults by causing cognitive impairment, falls, and hospitalisations. Many adverse drug reactions could be prevented with closer monitoring. This project will establish the effectiveness of the nurse-led intervention - the ADRe Profile - for medicines commonly prescribed in primary care and evaluate intervention implementation in general practices.

Conditions

  • Polypharmacy

Interventions

OTHER

Adverse Drug Reaction (ADRe) Profile

ADRe asks nurses to systematically check patients for the manifestation of itemised adverse side effects or undesirable effects of their primary care medicines, as listed in the BNF and manufacturers' Summaries of Product Characteristics (SmPCs), and seminal texts documenting known ADRs. Nurses are asked to share the identified problems with prescribers and pharmacists overseeing medicines charts.

Sponsors & Collaborators

  • Abertawe Bro Morgannwg University Health Board

    collaborator OTHER

  • Hywel Dda Health Board

    collaborator OTHER

  • Swansea University

    lead OTHER

Principal Investigators

  • Sue Jordan, PhD · Swansea University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-05
Primary Completion
2020-05-31
Completion
2020-10-04

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04663360 on ClinicalTrials.gov